260 related articles for article (PubMed ID: 24130910)
1. Aquaporin 2 mutations in Trypanosoma brucei gambiense field isolates correlate with decreased susceptibility to pentamidine and melarsoprol.
Graf FE; Ludin P; Wenzler T; Kaiser M; Brun R; Pyana PP; Büscher P; de Koning HP; Horn D; Mäser P
PLoS Negl Trop Dis; 2013; 7(10):e2475. PubMed ID: 24130910
[TBL] [Abstract][Full Text] [Related]
2. Chimerization at the AQP2-AQP3 locus is the genetic basis of melarsoprol-pentamidine cross-resistance in clinical Trypanosoma brucei gambiense isolates.
Graf FE; Baker N; Munday JC; de Koning HP; Horn D; Mäser P
Int J Parasitol Drugs Drug Resist; 2015 Aug; 5(2):65-8. PubMed ID: 26042196
[TBL] [Abstract][Full Text] [Related]
3. Melarsoprol sensitivity profile of Trypanosoma brucei gambiense isolates from cured and relapsed sleeping sickness patients from the Democratic Republic of the Congo.
Pyana Pati P; Van Reet N; Mumba Ngoyi D; Ngay Lukusa I; Karhemere Bin Shamamba S; Büscher P
PLoS Negl Trop Dis; 2014 Oct; 8(10):e3212. PubMed ID: 25275572
[TBL] [Abstract][Full Text] [Related]
4. Positively selected modifications in the pore of TbAQP2 allow pentamidine to enter
Alghamdi AH; Munday JC; Campagnaro GD; Gurvic D; Svensson F; Okpara CE; Kumar A; Quintana J; Martin Abril ME; Milić P; Watson L; Paape D; Settimo L; Dimitriou A; Wielinska J; Smart G; Anderson LF; Woodley CM; Kelly SPY; Ibrahim HM; Hulpia F; Al-Salabi MI; Eze AA; Sprenger T; Teka IA; Gudin S; Weyand S; Field M; Dardonville C; Tidwell RR; Carrington M; O'Neill P; Boykin DW; Zachariae U; De Koning HP
Elife; 2020 Aug; 9():. PubMed ID: 32762841
[TBL] [Abstract][Full Text] [Related]
5. Trypanosoma brucei aquaglyceroporin 2 is a high-affinity transporter for pentamidine and melaminophenyl arsenic drugs and the main genetic determinant of resistance to these drugs.
Munday JC; Eze AA; Baker N; Glover L; Clucas C; Aguinaga Andrés D; Natto MJ; Teka IA; McDonald J; Lee RS; Graf FE; Ludin P; Burchmore RJ; Turner CM; Tait A; MacLeod A; Mäser P; Barrett MP; Horn D; De Koning HP
J Antimicrob Chemother; 2014 Mar; 69(3):651-63. PubMed ID: 24235095
[TBL] [Abstract][Full Text] [Related]
6. Genotypic and phenotypic characterization of Trypanosoma brucei gambiense isolates from Ibba, South Sudan, an area of high melarsoprol treatment failure rate.
Maina N; Maina KJ; Mäser P; Brun R
Acta Trop; 2007; 104(2-3):84-90. PubMed ID: 17765860
[TBL] [Abstract][Full Text] [Related]
7. Comparative genomics of drug resistance in Trypanosoma brucei rhodesiense.
Graf FE; Ludin P; Arquint C; Schmidt RS; Schaub N; Kunz Renggli C; Munday JC; Krezdorn J; Baker N; Horn D; Balmer O; Caccone A; de Koning HP; Mäser P
Cell Mol Life Sci; 2016 Sep; 73(17):3387-400. PubMed ID: 26973180
[TBL] [Abstract][Full Text] [Related]
8. Transport proteins determine drug sensitivity and resistance in a protozoan parasite, Trypanosoma brucei.
Munday JC; Settimo L; de Koning HP
Front Pharmacol; 2015; 6():32. PubMed ID: 25814953
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics, Trypanosoma brucei gambiense efficacy, and time of drug action of DB829, a preclinical candidate for treatment of second-stage human African trypanosomiasis.
Wenzler T; Yang S; Braissant O; Boykin DW; Brun R; Wang MZ
Antimicrob Agents Chemother; 2013 Nov; 57(11):5330-43. PubMed ID: 23959303
[TBL] [Abstract][Full Text] [Related]
10. Genetic variants of the TbAT1 adenosine transporter from African trypanosomes in relapse infections following melarsoprol therapy.
Matovu E; Geiser F; Schneider V; Mäser P; Enyaru JC; Kaminsky R; Gallati S; Seebeck T
Mol Biochem Parasitol; 2001 Sep; 117(1):73-81. PubMed ID: 11551633
[TBL] [Abstract][Full Text] [Related]
11. Aquaglyceroporin 2 controls susceptibility to melarsoprol and pentamidine in African trypanosomes.
Baker N; Glover L; Munday JC; Aguinaga Andrés D; Barrett MP; de Koning HP; Horn D
Proc Natl Acad Sci U S A; 2012 Jul; 109(27):10996-1001. PubMed ID: 22711816
[TBL] [Abstract][Full Text] [Related]
12. Melarsoprol refractory T. b. gambiense from Omugo, north-western Uganda.
Matovu E; Enyaru JC; Legros D; Schmid C; Seebeck T; Kaminsky R
Trop Med Int Health; 2001 May; 6(5):407-11. PubMed ID: 11348535
[TBL] [Abstract][Full Text] [Related]
13. Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis.
Nok AJ
Parasitol Res; 2003 May; 90(1):71-9. PubMed ID: 12743807
[TBL] [Abstract][Full Text] [Related]
14. Instability of aquaglyceroporin (AQP) 2 contributes to drug resistance in Trypanosoma brucei.
Quintana JF; Bueren-Calabuig J; Zuccotto F; de Koning HP; Horn D; Field MC
PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008458. PubMed ID: 32644992
[TBL] [Abstract][Full Text] [Related]
15. In vitro drug sensitivity of Trypanosoma gambiense isolates.
Brun R; Baeriswyl S; Kunz C
Acta Trop; 1989 Oct; 46(5-6):369-76. PubMed ID: 2575872
[TBL] [Abstract][Full Text] [Related]
16. Melarsoprol- and pentamidine-resistant Trypanosoma brucei rhodesiense populations and their cross-resistance.
Bernhard SC; Nerima B; Mäser P; Brun R
Int J Parasitol; 2007 Nov; 37(13):1443-8. PubMed ID: 17602691
[TBL] [Abstract][Full Text] [Related]
17. Melarsoprol Resistance in African Trypanosomiasis.
Fairlamb AH; Horn D
Trends Parasitol; 2018 Jun; 34(6):481-492. PubMed ID: 29705579
[TBL] [Abstract][Full Text] [Related]
18. Functional analysis of drug resistance-associated mutations in the Trypanosoma brucei adenosine transporter 1 (TbAT1) and the proposal of a structural model for the protein.
Munday JC; Tagoe DN; Eze AA; Krezdorn JA; Rojas López KE; Alkhaldi AA; McDonald F; Still J; Alzahrani KJ; Settimo L; De Koning HP
Mol Microbiol; 2015 May; 96(4):887-900. PubMed ID: 25708978
[TBL] [Abstract][Full Text] [Related]
19. Differential virulence of Trypanosoma brucei rhodesiense isolates does not influence the outcome of treatment with anti-trypanosomal drugs in the mouse model.
Ndung'u K; Murilla GA; Thuita JK; Ngae GN; Auma JE; Gitonga PK; Thungu DK; Kurgat RK; Chemuliti JK; Mdachi RE
PLoS One; 2020; 15(11):e0229060. PubMed ID: 33151938
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of arsenical and diamidine uptake and resistance in Trypanosoma brucei.
Matovu E; Stewart ML; Geiser F; Brun R; Mäser P; Wallace LJ; Burchmore RJ; Enyaru JC; Barrett MP; Kaminsky R; Seebeck T; de Koning HP
Eukaryot Cell; 2003 Oct; 2(5):1003-8. PubMed ID: 14555482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
